ID
39922
Beschrijving
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Trefwoorden
Versies (2)
- 25-02-20 25-02-20 -
- 04-03-20 04-03-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
4 maart 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Concomitant medication
- StudyEvent: ODM
Beschrijving
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Beschrijving
Sequence Number
Datatype
integer
Alias
- UMLS CUI [1]
- C2348184
Beschrijving
(Trade Name preferred)
Datatype
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Beschrijving
In the original form this item is hidden.
Datatype
text
Alias
- UMLS CUI [1]
- C2826819
Beschrijving
In the original form this item is hidden.
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0871468
Beschrijving
In the original form this item is hidden.
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1516698
- UMLS CUI [1,3]
- C0805701
Beschrijving
In the original form this item is hidden.
Datatype
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Beschrijving
Unit Dose
Datatype
text
Alias
- UMLS CUI [1,1]
- C0869039
- UMLS CUI [1,2]
- C2347852
Beschrijving
Units of concomitant medication
Datatype
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C2347852
Beschrijving
Frequency of concomitant medication
Datatype
text
Alias
- UMLS CUI [1]
- C2826654
Beschrijving
Route of concomitant medication
Datatype
text
Alias
- UMLS CUI [1]
- C2826730
Beschrijving
Reason for Medication
Datatype
text
Alias
- UMLS CUI [1]
- C2826696
Beschrijving
day month year
Datatype
partialDate
Alias
- UMLS CUI [1]
- C2826734
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Beschrijving
Concomitant medication prior to study
Datatype
text
Alias
- UMLS CUI [1]
- C2826667
Beschrijving
If you tick No, please specify End date and time in the appropriate items.
Datatype
text
Alias
- UMLS CUI [1]
- C2826666
Beschrijving
day month year
Datatype
partialDate
Alias
- UMLS CUI [1]
- C2826744
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C2347852
Similar models
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
Geen commentaren